This report highlights that in 2002: the majority of scheme members submitted Annual Financial Returns in accordance with the agreed timetable and there was a fall in the average delay in submitting returns; the 4.5% price reduction continued to deliver annual savings to the NHS of some £200 million; and the improved allowances of up to 23% of NHS sales for research and development (R&D) continued to provide significant support for R&D and innovation.
Contact details for obtaining hard-copy DH publications.

Useful tips to ensure you get the most from PDFs and the free Reader program. Topics covered include accessibility, troubleshooting and searching files.